Member of Congress
Byron Donalds
- Role
- Current Representative
- State
- FL
- Party
- Republican
Cosponsored legislation
H.R. 6832 · 117th Congress
To amend the Federal Food, Drug, and Cosmetic Act and the Defense Production Act of 1950 to prohibit the Federal Government from limiting State access to key therapies, such as monoclonal antibodies, and from prioritizing Federal contracts over State contracts relating to purchasing supplies to combat the COVID-19 pandemic.
H.R. 6829 · 117th Congress
Freedom to Fly Maskless Act of 2022
H.R. 6422 · 117th Congress
Putin Accountability Act
H.Res. 934 · 117th Congress
Supporting reopening the United States Capitol and House Office Buildings to the American people.
H.R. 6840 · 117th Congress
Northern Border Reopening Act
H.R. 6820 · 117th Congress
CRISIS Act
H.R. 6773 · 117th Congress
Protecting Federal Funds from Human Trafficking and Smuggling Act of 2022
H.R. 6686 · 117th Congress
Sanctioning Tyrannical and Oppressive People within the Chinese Communist Party Act
H.R. 6771 · 117th Congress
South Florida Ecosystem Enhancement Act of 2022
H.R. 6415 · 117th Congress
To amend the Federal Reserve Act to prohibit the Federal reserve banks from offering certain products or services directly to an individual, and for other purposes.
H.R. 2252 · 117th Congress
Emmett Till and Mamie Till-Mobley Congressional Gold Medal Act of 2021
H.R. 5770 · 117th Congress
Forage Fish Conservation Act of 2021
H.R. 3896 · 117th Congress
Critical Mineral Access Act
H.R. 6522 · 117th Congress
Stop the Betrayal Act of 2022
H.R. 6558 · 117th Congress
Securing Enfranchisement and the Rights of Voters regardless of Inoculation Status Act
H.R. 6764 · 117th Congress
Preventing Violence Against Female Inmates Act of 2022
H.R. 6750 · 117th Congress
More Accurate Metrics in Securities Law Act
H.R. 6711 · 117th Congress
Stop Funding Our Adversaries Act of 2022
H.R. 6710 · 117th Congress
To direct the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to submit to Congress a report on barriers, including regulatory inefficiencies, to domestic manufacturing of active pharmaceutical ingredients, finished drug products, and devices, and for other purposes.
H.R. 2192 · 117th Congress
Camp Lejeune Justice Act of 2021
H.R. 6636 · 117th Congress
Due Process Continuity of Care Act
H.R. 6628 · 117th Congress
Close Biden’s Open Border Act
H.R. 6610 · 117th Congress
Border Czar Accountability Act of 2022
H.R. 6592 · 117th Congress
Immigration Transparency and Transit Notification Act of 2022
H.R. 6544 · 117th Congress